With the Us market for blood plasma appearing soft, CSL will be anxious to leverage of its pipeline to make up any profit deficiencies.
We are all expecting news on the CSL collaboration and I believe the timing for POH could not be better if we get any positive news on the CSL front.
- Forums
- ASX - By Stock
- AVE
- csl biotherapies
csl biotherapies
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 43869108 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 44263580 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 43869108 | 0.002 |
16 | 22966742 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 44170247 | 21 |
0.004 | 34681763 | 17 |
0.005 | 16900219 | 10 |
0.006 | 9723435 | 9 |
0.007 | 13229103 | 6 |
Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
AVE (ASX) Chart |
Day chart unavailable